The first clinical trial begins to solve the folding of the liver caused by protein Z
The human trial begins, of the treatment that acts on the liver, due to the protein Alpha-1 Antitrypsin. Almost all cases of AATD are caused by a single mutation in the A1AT gene, known as the ‘Z mutation’. Z Factor, the Cambridge-based drug development company, has administered the first human volunteer ZF874, their novel treatment […]
The first clinical trial begins to solve the folding of the liver caused by protein Z Read More »